Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) Short Interest Update

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) saw a large decrease in short interest in the month of August. As of August 14th, there was short interest totaling 118,989 shares, a decrease of 47.0% from the July 30th total of 224,453 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average daily volume of 157,426 shares, the days-to-cover ratio is presently 0.8 days.

Analyst Ratings Changes

Separately, Kepler Capital Markets raised Coloplast A/S to a “strong-buy” rating in a report on Wednesday, May 20th. One analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Coloplast A/S currently has an average rating of “Hold”.

Coloplast A/S Price Performance

CLPBY stock opened at $7.14 on Tuesday. The company’s 50-day moving average price is $6.47 and its two-hundred day moving average price is $6.60. The firm has a market cap of $16.09 billion, a P/E ratio of 37.58, a P/E/G ratio of 2.70 and a beta of 0.13. The company has a quick ratio of 1.09, a current ratio of 1.75 and a debt-to-equity ratio of 1.66. Coloplast A/S has a 12 month low of $5.64 and a 12 month high of $10.03.

Coloplast A/S (OTCMKTS:CLPBY) last posted its earnings results on Tuesday, August 18th. The company reported $0.10 EPS for the quarter, hitting the consensus estimate of $0.10. Coloplast A/S had a net margin of 9.68% and a return on equity of 38.81%. The business had revenue of $1.14 billion for the quarter, compared to the consensus estimate of $1.11 billion. On average, analysts anticipate that Coloplast A/S will post 0.4 earnings per share for the current fiscal year.

About Coloplast A/S

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.